Trial Profile
Circulating Tumor Cells in Patients with Castration Resistant Metastatic Prostate Cancer Undergoing Zoledronate Therapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Feb 2014
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- Acronyms Cicero-Z
- 29 Apr 2012 New trial record